337 related articles for article (PubMed ID: 22172433)
21. Androgen Therapy in Women.
Vegunta S; Kling JM; Kapoor E
J Womens Health (Larchmt); 2020 Jan; 29(1):57-64. PubMed ID: 31687883
[TBL] [Abstract][Full Text] [Related]
22. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.
Buster JE; Kingsberg SA; Aguirre O; Brown C; Breaux JG; Buch A; Rodenberg CA; Wekselman K; Casson P
Obstet Gynecol; 2005 May; 105(5 Pt 1):944-52. PubMed ID: 15863529
[TBL] [Abstract][Full Text] [Related]
23. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS).
Leiblum SR; Koochaki PE; Rodenberg CA; Barton IP; Rosen RC
Menopause; 2006; 13(1):46-56. PubMed ID: 16607098
[TBL] [Abstract][Full Text] [Related]
24. Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen.
Nachtigall L; Casson P; Lucas J; Schofield V; Melson C; Simon JA
Gynecol Endocrinol; 2011 Jan; 27(1):39-48. PubMed ID: 21142609
[TBL] [Abstract][Full Text] [Related]
25. Lasofoxifene and cardiovascular events in postmenopausal women with osteoporosis: Five-year results from the Postmenopausal Evaluation and Risk Reduction with Lasofoxifene (PEARL) trial.
Ensrud K; LaCroix A; Thompson JR; Thompson DD; Eastell R; Reid DM; Vukicevic S; Cauley J; Barrett-Connor E; Armstrong R; Welty F; Cummings S
Circulation; 2010 Oct; 122(17):1716-24. PubMed ID: 20937977
[TBL] [Abstract][Full Text] [Related]
26. Testosterone therapy for sexual dysfunction in postmenopausal women.
Hubayter Z; Simon JA
Climacteric; 2008 Jun; 11(3):181-91. PubMed ID: 18568783
[TBL] [Abstract][Full Text] [Related]
27. Testosterone supplementation for hypoactive sexual desire disorder in women.
Woodis CB; McLendon AN; Muzyk AJ
Pharmacotherapy; 2012 Jan; 32(1):38-53. PubMed ID: 22392827
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial.
Davis S; Papalia MA; Norman RJ; O'Neill S; Redelman M; Williamson M; Stuckey BG; Wlodarczyk J; Gard'ner K; Humberstone A
Ann Intern Med; 2008 Apr; 148(8):569-77. PubMed ID: 18413618
[TBL] [Abstract][Full Text] [Related]
29. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2005; 12(5):496-511; quiz 649. PubMed ID: 16145303
[TBL] [Abstract][Full Text] [Related]
30. Role of testosterone in the treatment of hypoactive sexual desire disorder.
Schwenkhagen A; Studd J
Maturitas; 2009 Jun; 63(2):152-9. PubMed ID: 19359109
[TBL] [Abstract][Full Text] [Related]
31. A case series of androgen use in breast cancer survivors with sexual dysfunction.
Krychman ML; Stelling CJ; Carter J; Hudis CA
J Sex Med; 2007 Nov; 4(6):1769-74. PubMed ID: 17666036
[TBL] [Abstract][Full Text] [Related]
32. Testosterone therapy in women: a review.
Bolour S; Braunstein G
Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
[TBL] [Abstract][Full Text] [Related]
33. Testosterone patch: new drug. Don't use to stimulate women's sexual desire.
Prescrire Int; 2007 Oct; 16(91):190-2. PubMed ID: 17926827
[TBL] [Abstract][Full Text] [Related]
34. Safety of testosterone use in women.
Shufelt CL; Braunstein GD
Maturitas; 2009 May; 63(1):63-6. PubMed ID: 19250779
[TBL] [Abstract][Full Text] [Related]
35. Androgen treatment of postmenopausal women.
Davis SR; Worsley R
J Steroid Biochem Mol Biol; 2014 Jul; 142():107-14. PubMed ID: 23727129
[TBL] [Abstract][Full Text] [Related]
36. Hypoactive Sexual Desire Disorder and current pharmacotherapeutic options in women.
Palacios S
Womens Health (Lond); 2011 Jan; 7(1):95-107. PubMed ID: 21175394
[TBL] [Abstract][Full Text] [Related]
37. Transdermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: a controlled pilot study of the effects on the arizona sexual experiences scale for females and sexual function questionnaire.
Chudakov B; Ben Zion IZ; Belmaker RH
J Sex Med; 2007 Jan; 4(1):204-208. PubMed ID: 17233786
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women.
West SL; D'Aloisio AA; Agans RP; Kalsbeek WD; Borisov NN; Thorp JM
Arch Intern Med; 2008 Jul; 168(13):1441-9. PubMed ID: 18625925
[TBL] [Abstract][Full Text] [Related]
39. Testosterone and the breast.
Shufelt CL; Braunstein GD
Menopause Int; 2008 Sep; 14(3):117-22. PubMed ID: 18714077
[TBL] [Abstract][Full Text] [Related]
40. Which Postmenopausal Women Should Use Testosterone for Low Sexual Desire?
Slomski A
JAMA; 2020 Feb; 323(6):493-495. PubMed ID: 31968073
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
